Targeting Oxalate Production by Combining Enzyme Inhibition and Proteolysis Activation: A Novel Therapeutic Approach for Primary Hyperoxaluria Type 1.

Treatment with compound 2 resulted in an approximately 87% decrease in total number of crystals ( Figure E), accompanied by a decreasing trend in the size of the largest crystal per field of view ( Figure F).

also in 47,180 other papers